Patents by Inventor Nattharika Aumsuwan

Nattharika Aumsuwan has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20120161783
    Abstract: A dry gel-conductive sensor. In embodiments, the sensor comprises a scaffold structure which comprises a structure and a covering. A conductive material, which is both ionically and electronically conductive, may be dispersed within the structure. According to an embodiment, the covering comprises openings which allow conductive material through the covering to contact the skin of a subject. The covering may additionally or alternatively comprise brush-like features configured to penetrate through hair.
    Type: Application
    Filed: December 21, 2011
    Publication date: June 28, 2012
    Applicant: ADVANCED BRAIN MONITORING, INC.
    Inventors: Christine Berka, Daniel J. Levendowski, Giby Raphael, Djordje Popovic, Catherine N. Skelton, Jamshid Avloni, Nattharika Aumsuwan
  • Patent number: 7854941
    Abstract: Polymers are disclosed that are chemically modified to retard bacterial growth. Such modified polymers (e.g. ePTFE and polypropylene) are produced by first creating acid groups on the polymer surface through reactions with an anhydride. The acid groups are then linked to polyethylene glycol (PEG) through esterification or other reactions such as amidation. Preferably, at least two different molecular weight PEG species are employed. The antimicrobial surface is completed by linking antibiotics (e.g. ?-lactam antibiotics) to the PEG extensions. One preferred embodiment of such a modified polymer is produced using ePTFE, maleic anhydride (MA), and penicillin (PEN) to yield PEN-PEG-MA-ePTFE, which inhibits gram-positive bacteria. The PEG spacer is critical for PEN function in this context, since PEN-ePTFE is ineffective against bacterial growth. Another preferred embodiment incorporates ampicillin (AMP) and a heterobifunctional PEG, HOOC—(CH2—CH2—O)n—NH2, to yield AMP-PEG-MA-ePTFE.
    Type: Grant
    Filed: February 12, 2008
    Date of Patent: December 21, 2010
    Assignee: The University of Southern Mississippi
    Inventors: Marek W. Urban, Nattharika Aumsuwan
  • Publication number: 20080207535
    Abstract: Polymers are disclosed that are chemically modified to retard bacterial growth. Such modified polymers (e.g. ePTFE and polypropylene) are produced by first creating acid groups on the polymer surface through reactions with an anhydride. The acid groups are then linked to polyethylene glycol (PEG) through esterification or other reactions such as amidation. Preferably, at least two different molecular weight PEG species are employed. The antimicrobial surface is completed by linking antibiotics (e.g. ?-lactam antibiotics) to the PEG extensions. One preferred embodiment of such a modified polymer is produced using ePTFE, maleic anhydride (MA), and penicillin (PEN) to yield PEN-PEG-MA-ePTFE, which inhibits gram-positive bacteria. The PEG spacer is critical for PEN function in this context, since PEN-ePTFE is ineffective against bacterial growth. Another preferred embodiment incorporates ampicillin (AMP) and a heterobifunctional PEG, HOOC—(CH2—CH2—O)n—NH2, to yield AMP-PEG-MA-ePTFE.
    Type: Application
    Filed: February 12, 2008
    Publication date: August 28, 2008
    Inventors: Marek W. Urban, Nattharika Aumsuwan